| |
A- peptide titration
|
B- serum titration
|
C-competition (peptide titration)
|
D-competition (Antibody titration)
|
|---|
| |
Kp
|
Amax
|
Ka
|
Amax
|
Kd
|
Amax
|
Kd
|
Amax
|
|
1
|
↓
|
↑
|
↓
|
↑
|
↑
|
↑
| | |
|
2
|
↓
|
↑
|
↓
|
↑
|
↑
|
↑
| | |
|
3
|
↓
|
↑
|
↔
|
↑
|
↑
|
↑
| | |
|
4
|
↓
|
↑
|
↓
|
↑
|
↑
|
↑
| | |
|
5
|
↓
|
↑
|
↓
|
↑
| | | | |
|
6
|
↓
|
↑
| | |
↑
|
↑
|
↑
|
↑
|
|
7
|
↓
|
↑
| | | | |
↑
|
↑
|
|
8
|
↓
|
↑
| | | | |
↑
|
↑
|
|
9
|
↓
|
↑
| | | | |
↑
|
↑
|
|
10
| | | | |
↑
|
↑
|
↑
|
↑
|
|
11
|
↓
|
↑
| | |
↑
|
↑
|
↑
|
↑
|
- A-the effect of increasing the amount of antibody.
- B- the effect of increasing the amount of attached peptide.
- C- the effect of increasing the amount of attached peptide on the parameters of the competition.
- D- the effect of increasing the amount of antibody on the parameters of the competition.
- (1)MXR P5/#853, (2) MXR P5/#851, (3) MXR P2/#850, (4) MXR P2/#795, (5) MXR P3/#795, (6) MXR P1/#841, (7) ATP P1/#840, (8) ATP P3/#855, (9) ATP P4/# 485, (10) MRP P1/#151 #152,(11) MRP P2/#151 & #152
